Fecal microbiota transplantation augmented by a sulfide-reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis

被引:8
|
作者
Bryant, Robert, V [1 ,2 ,3 ]
Day, Alice S. [1 ,2 ]
McGrath, Ken C. [4 ]
Telfer, Karmen [1 ,2 ]
Yao, Chu K. [5 ]
Costello, Samuel P. [1 ,2 ,3 ]
机构
[1] Queen Elizabeth Hosp, Dept Gastroenterol & Hepatol, IBD Serv, 28 Woodville Rd,Woodville South, Adelaide, SA 5022, Australia
[2] Univ Adelaide, Sch Med, Fac Hlth Sci, Adelaide, SA, Australia
[3] Biomebank, Thebarton, SA, Australia
[4] Microba, Brisbane, Qld, Australia
[5] Monash Univ, Alfred Hosp, Translat Nutrit Sci, Dept Gastroenterol, Melbourne, Vic, Australia
来源
JGH OPEN | 2021年 / 5卷 / 09期
关键词
diet; fecal microbiota transplantation; metagenomics; refractory ulcerative colitis;
D O I
10.1002/jgh3.12623
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Fecal microbiota transplantation (FMT) is effective for induction of remission in ulcerative colitis (UC). Diet has potential to augment the efficacy and durability of FMT by encouraging engraftment of transplanted microorganisms. A trial of FMT combined with a defined diet was undertaken as salvage therapy for a 71-year-old woman with active steroid-refractory extensive UC. A multidimensional sulfide-reducing diet (4-SURE diet) was commenced followed by single-donor FMT administered by colonoscopy and then enemas over 7 days. Dietary adherence, clinical evaluation, and stool samples for metagenomic profiling were undertaken at weeks 0, 4, 8, and 24. Colonoscopy was performed 8 weeks post-FMT. Shotgun metagenomic profiling of the donor fecal suspension was also performed. A rapid clinical response to FMT and 4-SURE diet was observed with normalization of stool frequency (<= 2 motions/day) and resolution of rectal bleeding within 2 weeks. Dietary adherence was excellent. Colonoscopy at week 8 revealed no evidence of active colitis (Mayo endoscopic sub-score 0) with histology showing no evidence of acute or chronic lamina propria inflammatory cell infiltrate. Sustained clinical and endoscopic remission out to 24 weeks was observed. Metagenomic sequencing confirmed sustained engraftment of beneficial donor microbiota with increased alpha-diversity and capacity for short-chain fatty acid production, including Faecalibacterium prauznitzii and Eubacterium hallii. This case report supports the rationale of prescribed diet therapy to support engraftment of donor microbiota following FMT for UC. Further large trials with a diet-arm control group are needed to evaluate FMT augmented by a defined diet in UC.
引用
收藏
页码:1099 / 1102
页数:4
相关论文
共 50 条
  • [41] Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis
    Mintz, Michael
    Khair, Shanawaj
    Grewal, Suman
    LaComb, Joseph F.
    Park, Jiyhe
    Channer, Breana
    Rajapakse, Ramona
    Bucobo, Juan Carlos
    Buscaglia, Jonathan M.
    Monzur, Farah
    Chawla, Anupama
    Yang, Jie
    Robertson, Charlie E.
    Frank, Daniel N.
    Li, Ellen
    PLOS ONE, 2018, 13 (01):
  • [42] FECAL MICROBIOTA TRANSPLANTATION IS EFFICACIOUS TO ACHIEVE CLINICAL RESPONSE AND REMISSION IN ADULT PATIENTS WITH ULCERATIVE COLITIS; A META-ANALYSIS
    Kashani, Amir
    Shih, David Q.
    GASTROENTEROLOGY, 2017, 152 (05) : S988 - S989
  • [43] Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis
    Scaldaferri, F.
    Pecere, S.
    Petito, V.
    Zambrano, D.
    Fiore, L.
    Lopetuso, L. R.
    Schiavoni, E.
    Bruno, G.
    Gerardi, V.
    Laterza, L.
    Pizzoferrato, M.
    Ianiro, G.
    Stojanovic, J.
    Poscia, A.
    Papa, A.
    Sterbini, F. P.
    Sanguinetti, M.
    Masucci, L.
    Cammarota, G.
    Gasbarrini, A.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (02) : 402 - 407
  • [44] Infliximab as Therapeutic Option in Steroid-Refractory Ulcerative Colitis after Kidney Transplantation: Case Report
    Temme, J.
    Koziolek, M.
    Bramlage, C.
    Schaefer, I. M.
    Fuezesi, L.
    Ramadori, G.
    Mueller, G. A.
    Schwoerer, H.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3880 - 3882
  • [45] Polyethylene Glycol induced Acute Pancreatitis following Colonoscopic Fecal Microbiota Transplant for Severe Ulcerative Colitis: A Case Report
    Seth, Avnish Kumar
    Gupta, Mahesh Kumar
    Bansal, Rinkesh Kumar
    Kaur, Gursimran
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 106 - 106
  • [46] Polyethylene Glycol induced Acute Pancreatitis following Colonoscopic Fecal Microbiota Transplant for Severe Ulcerative Colitis: A Case Report
    Seth, Avnish Kumar
    Gupta, Mahesh Kumar
    Bansal, Rinkesh Kumar
    Kaur, Gursimran
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 778 - 778
  • [47] THE SAFETY AND BENEFITS OF THE IMPROVED LAB PROCESS OF FECAL MICROBIOTA TRANSPLANTATION TO PATIENTS WITH REFRACTORY ULCERATIVE COLITIS: A STUDY FROM THE LARGEST FMT CENTER IN CHINA
    Zhang, Faming
    Ding, Xiao
    Li, Qianqian
    Li, Pan
    Zhang, Ting
    Cui, Bota
    Ji, Guozhong
    GASTROENTEROLOGY, 2018, 154 (06) : S1037 - S1037
  • [48] Recurrence of moderate to severe ulcerative colitis after fecal microbiota transplantation treatment and the efficacy of re-FMT: a case series
    Xiao-Fei Dang
    Zhao Qing-Xi Wang
    Lin Yin
    Wei-Hua Sun
    BMC Gastroenterology, 20
  • [49] Recurrence of moderate to severe ulcerative colitis after fecal microbiota transplantation treatment and the efficacy of re-FMT: a case series
    Dang, Xiao-Fei
    Wang, Qing-Xi
    Yin, Zhao
    Sun, Lin
    Yang, Wei-Hua
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [50] Complementary Therapeutic Effect of Fecal Microbiota Transplantation in Ulcerative Colitis after the Response to Anti-Tumor Necrosis Factor Alpha Agent Was Lost: A Case Report
    Shin, Jongbeom
    Baek, Ga Hyeon
    Cha, Boram
    Park, Soo-Hyun
    Lee, Jung-Hwan
    Kim, Jun-Seob
    Kwon, Kye Sook
    BIOMEDICINES, 2024, 12 (04)